Moody Aldrich Partners’s Ventyx Biosciences VTYX Stock Holding History

Moody Aldrich Partners’s Portfolio VTYX Stock Details VTYX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-262,938	Closed	-$2.37M	–	213
2025 Q4	$2.37M	Buy	+262,938	New	+$1.97M	0.44%	98
2023 Q4	–	Sell	-37,988	Closed	-$1.32M	–	225
2023 Q3	$1.32M	Buy	37,988 +1,491	+4%	+$51.5K	0.25%	105
2023 Q2	$1.2M	Sell	36,497 -53	-0.1%	-$1.83K	0.23%	113
2023 Q1	$1.22M	Sell	36,550 -42,700	-54%	-$1.66M	0.25%	114
2022 Q4	$2.6M	Buy	+79,250	New	+$2.35M	0.53%	71

Other funds holding VTYX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Moody Aldrich Partners's VTYX Position: Q1 2026 in Review

Moody Aldrich Partners sold out of Ventyx Biosciences (VTYX) in Q1 2026, closing a stake of 262,938 shares — an estimated $2.37M sold.

Moody Aldrich Partners first reported a position in VTYX in Q4 2022 and held it in 5 quarters. The position peaked at $2.6M in Q4 2022. 1 fund tracked by Wall St. Rank holds VTYX as of Q1 2026.

Moody Aldrich Partners reported no remaining Ventyx Biosciences position as of Q1 2026 after selling out during the quarter.
Moody Aldrich Partners sold 262,938 Ventyx Biosciences shares in Q1 2026, an estimated $2.37M.
Moody Aldrich Partners first reported a position in Ventyx Biosciences in Q4 2022 and held it in 5 quarters.
Moody Aldrich Partners's Ventyx Biosciences position peaked at $2.6M in Q4 2022.
1 fund tracked by Wall St. Rank held Ventyx Biosciences as of Q1 2026.

Based on Moody Aldrich Partners's 13F filing for Q1 2026, filed 20 Apr 2026.